-
Taxonomy & unit
-
us-gaap: GBP
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
TC BioPharm (Holdings) plc annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q1 2024.
- TC BioPharm (Holdings) plc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -£3.32M, a 423% decline year-over-year.
- TC BioPharm (Holdings) plc annual Net Income (Loss) Attributable to Parent for 2024 was -£12.2M, a 106% decline from 2023.
- TC BioPharm (Holdings) plc annual Net Income (Loss) Attributable to Parent for 2023 was -£5.91M, a 350% decline from 2022.
Net Income (Loss) Attributable to Parent, Quarterly (GBP)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)